Monday, May 5, 2025 The S&P 500 registered its first down-day in the stock market in the past 10 sessions. Warren Buffett announcing he is stepping down from his post as President and CEO of Berkshire Hathaway (BRK.B) had a negative effect on not just Berkshire shares, but Apple AAPL shares as well; Berkshire is a major holder of Apple Inc. Overall, we saw the Dow slip -98 points on the day, -0.24%, with the S&P 500 -36 points, -0.64%. The tech-heavy Nasdaq and the small-cap Russell 2000 were in a race to the bottom of the major indexes today: the Nasdaq fell -133 points, -0.74%, while the Russell 2000 was off -16 points, -0.82%. Services Sector Gives Mixed Results for April After today’s opening bell this morning, we saw two separate reports on the U.S. Services sector for the month of April. These metrics do not always move in lock-step with one another, but today they moved in clearly opposite directions: S&P final Services PMI came in at 50.8 — slightly below the 51.0 estimate, and 60 basis points (bps) beneath the previous read of 51.4. ISM Services reached 51.6% today — nicely ahead of the 50.4% estimate and 50.8% reported earlier. Q1 Earnings Reports After the Bell: Ford, Palantir & More Shares of Ford Motor Co. F are down -2% following the U.S. automaker’s Q1 beats on both top and bottom lines this afternoon. Earnings of 14 cents per share easily surpassed the $0.00 per share expected — a figure that the company had guided down toward a couple weeks ago. Revenues of $37.42 billion were almost $2 billion ahead of the consensus estimate $35.48 billion. However, Ford has suspended its full-year guidance at this time, citing tariff implications which the automaker expects will cost the company $1.5 billion this year. That’s equal to the cash burn reported in today’s release: $1.5 billion. Ford shares are now trading basically flat from the first of the year. Check out the updated Zacks Earnings Calendar here. Palantir PLTR, on the other hand, is the stock market’s biggest gainer this year so far, and its Q1 report this afternoon has sent after-market activity into a volatile tizzy. The defense software analytics company only just met expectations on earnings of 13 cents per share, whereas revenues of $884 million surged past the $863 million in the Zacks consensus. U.S. government revenue grew +43% year over year. The company also upped guidance for next quarter and the full year: to a range of $934-938 million for the quarter (from $898.5 million forecast) and to $3.89-3.96 billion (from $3.77 billion previously expected). But shares are down -8% on the news, after having grown +63% from the first of the year and +390% from this time last year. Clorox CLX missed expectations on both top and bottom lines in its fiscal Q3 results after the closing bell today: earnings of $1.47 per share missed the $1.57 expected (and $1.71 per share from the year-ago quarter) on $1.67 billion in revenues which missed the $1.71 billion anticipated. Fill-year earnings remain in the previous range, but next-quarter guidance has come down. Shares are lower -4% in late trading. Hims & Hers HIMS telehealth firm solidly beat Q1 expectations on both top and bottom lines today — earnings of 20 cents per share on $586 million in revenues outpaced the 12 cents per share on $538.1 million in sales estimated, but then guided lower on revenues for the current quarter. The company also announced it would have access to disburse weigh-loss drug Wegovy, and has nabbed long-time Amazon AMZN executive Nader Kabbani as its new COO. Shares are up slightly in late trading. Questions or comments about this article and/or author? Click here>> Story Continues Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amazon.com, Inc. (AMZN):Free Stock Analysis Report Ford Motor Company (F):Free Stock Analysis Report Apple Inc. (AAPL):Free Stock Analysis Report Berkshire Hathaway Inc. (BRK.B):Free Stock Analysis Report The Clorox Company (CLX):Free Stock Analysis Report Palantir Technologies Inc. (PLTR):Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Trading Week Starts Out on the Soft Side
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...